| |
|
|
|
|
| |
PRODUCTS |
PHONE: 614.888.2855 |
|
|
 |
|
|
 |
|
|
| Obagi® Skin Care Products |
|
Do you believe in transformation? You will! The Obagi Nu-Derm System transforms skin’s cellular function to help it look and act younger and healthier.
Aging and environmental factors slow down skin cell functions.
• Skin functions slow as we age
• Skin becomes more fragile and less healthy
• Daily abuse of environmental factors accelerate aging
Damaged skin cell functions cause skin cell turnover to slow significantly, over produce melanin, damage collagen, and weaken connective tissue. The result is fragile skin that has hyperpigmentation and dark spots, wrinkles, and laxity.
The solution is the Obagi Nu-Derm System. Nu-Derm accelerates skin cell functions by triggering the Therapeutic Cascade. It corrects premature damage, reduces future damage, and helps skin look and act younger and healthier. The system stimulates cellular turnover rate which continually pushes fresher cells to the surface of your skin more quickly. It corrects hyperpigmentation and distributes melanin evenly. Nu-Derm also causes the skin’s basal layer to produce cells that are more uniform providing better skin structure. It also increases collagen and elastin formation resulting in stronger, more resilient skin.
The skin of your youth is waiting to emerge! Let Obagi help!
If you are interested on learning more about all the Obagi products and the science of skin transformation, please call us to schedule a complimentary consultation. Obagi products are available at both our Akron and Powell locations.
|
|
|
|
| |
| |
|
|
|
|
|
| |
 |
|
|
|
| Headquartered in Long Beach, California, Obagi Medical Products is a pharmaceutical company that develops, manufactures, markets and sells proprietary prescription skin care Systems. The Systems are designed to prevent and improve the most common and visible skin disorders in adult skin. The Obagi Nu-Derm System products were created in 1988 by Dr. Zein E. Obagi and other leading... go to site |
|
|
|
|
|
|
|
|
|
|
|
|
| |
|
|
